Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 4

Blood Cancer Journal

A retrospective review of DLBCL patients treated at MSKCC w/HD MTX ppx failed to show a persistent benefit in decreasing CNS relapse rates. This

  • A retrospective review of DLBCL patients treated at MSKCC w/HD MTX ppx failed to show a persistent benefit in decreasing CNS relapse rates. This study adds to the recent data questioning the utility of CNS prophylaxis.